Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of Medical Virology"
DOI: 10.1002/jmv.26916
Abstract: This study aimed to explore the value of baseline serum exosome‐derived miRNAs for predicting HBeAg seroconversion in chronic hepatitis B (CHB) patients treated with peginterferon (Peg‐IFN). A total of 120 treatment‐naïve HBeAg‐positive CHB patients who…
read more here.
Keywords:
hbeag seroconversion;
mir;
baseline serum;
serum ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Antiviral research"
DOI: 10.1016/j.antiviral.2020.104719
Abstract: The progression of chronic hepatitis B (CHB) is associated with single-nucleotide polymorphisms (SNPs). In this study, we demonstrated the association between immune-related SNPs and delayed spontaneous HBeAg seroconversion in immune-active CHB patients. In addition, we…
read more here.
Keywords:
immune active;
seroconversion;
immune related;
delayed spontaneous ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of pharmaceutical and biomedical analysis"
DOI: 10.1016/j.jpba.2021.114349
Abstract: Chronic hepatitis B (CHB) remains a major public health problem globally. HBeAg seroconversion is a vital hallmark for the improvement of CHB. The plasma metabolic profile has not been clear in CHB patients and searching…
read more here.
Keywords:
seroconversion;
hbeag seroconversion;
metabolic profiles;
chb patients ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Medicine"
DOI: 10.1097/md.0000000000006242
Abstract: Abstract Effective antiviral therapy plays a key role in slowing the progression of chronic hepatitis B (CHB). Identification of serum indices, including hepatitis B e antigen (HBeAg) expression and seroconversion, will facilitate evaluation of the…
read more here.
Keywords:
seroconversion;
treatment;
chronic hepatitis;
hbeag seroconversion ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal of Viral Hepatitis"
DOI: 10.1111/jvh.13787
Abstract: There is no satisfactory standard for predicting HBeAg seroconversion during Pegylated interferon alpha (PegIFNα) treatment. Studies have shown that IFNα therapy in chronic hepatitis C patients could alter serum lipid profiles. However, there have been…
read more here.
Keywords:
chronic hepatitis;
pegylated interferon;
hbeag seroconversion;
seroconversion ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Liver International"
DOI: 10.1111/liv.13314
Abstract: Treatment with nucleoside analogue (NAs) is now the most common treatment for chronic hepatitis B (CHB) and is recommended by all guidelines. Stopping NAs is a controversial issue in these patients, unless the clinical endpoints…
read more here.
Keywords:
treatment;
relapse;
chronic hepatitis;
hbeag seroconversion ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Viruses"
DOI: 10.3390/v11080687
Abstract: It is well appreciated that ethnicity influences the natural history and immune responses during a chronic hepatitis B infection. In this study, we explore the effect of ethnicity and treatment cessation on Hepatitis B surface…
read more here.
Keywords:
ethnicity;
hbsag loss;
treatment;
treatment cessation ... See more keywords